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Background and aims: Physical activity is important for muscle and bone strength in the growing
child and may be impaired in paediatric patients with inflammatory bowel disease (IBD) even
during quiescent disease. The SenseWearPro2 armband allows to measure physical activity
under everyday life conditions.
Methods: Thirty-nine IBD patients (27 Crohn's disease, 12 ulcerative colitis, 24 boys) in remission
(n=26) or with only mild disease activity (n=13) were compared to 39 healthy age and sex-
matched controls. Body weight, height, body mass index (BMI), lean body mass as phase angle
α (determined by bioelectrical impedance analysis), and dynamometric grip force were
expressed as age- and sex-related Z-scores. SenseWearPro2 armbands were applied for three
consecutive days to record number of steps, duration of physical activity and sleeping time.
Quality of life was assessed with the German KINDL and IMPACT III questionnaires, energy intake
with prospective food protocols. Differences between patients and pair-matched controls were
analysed by paired t-test.BD, Inflammatory Bowel Disease; LBM, Lean Body Mass; MET, Metabolic Equivalent of Task; QoL, Quality of
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666 K.J. Werkstetter et al.Results: Patients showed lower Z-scores for phase angle α (difference −0.72; 95% CI [−1.10;
−0.34]) and lower grip strength (−1.02 [−1.58; −0.47]) than controls. They tended towards less-
er number of steps per day (−1339 [−2760; 83]) and shorter duration of physical activity
(−0.44 h [−0.94; 0.06]), particularly in females and patients with mild disease. Quality of life
and energy intake did not differ between patients and controls.
Conclusion: In spite of quiescent disease lean body mass and physical activity were reduced.
Interventions to encourage physical activity may be beneficial in this lifelong disease.
© 2011 European Crohn’s and Colitis Organisation. Published by Elsevier B.V. All rights reserved.1. Introduction
Physical activity plays a major role in the normal develop-
ment and growth during the first phase of life. Children
and adolescents benefit from the effects of exercise in
respect to physical fitness (cardiorespiratory efficiency,
muscular strength, and endurance), bone strength, cognitive
functions, and psycho-social factors (self-efficacy, self-worth
and self-esteem).1
Reduced physical activity is a risk factor for several
chronic conditions, e.g. cardiovascular diseases, diabetes
or osteoporosis.2 Low physical exercise during childhood
and adolescence is associated with sedentary behaviour in
adulthood and therefore may increase the risk for these
negative health consequences.3
Children and adolescents with chronic disorders, like ju-
venile arthritis or asthma, are reported to be less physically
active.4 To our knowledge, no data have been published on
physical activity in paediatric IBD, particularly in children
with well-controlled disease. We consider it likely that phys-
ical exercise is reduced during moderate to severe disease
activity or after surgery, but these are transient conditions
in most patients. During remission or intervals of mild
inflammation, exercise is not contraindicated5; though
patients may tend to lower physical activity.
This study aims to answer the question whether physical
activity in paediatric IBD patients is reduced compared to
age- and sex-matched healthy controls even during phases
of quiescent disease. Since we focused on everyday life
physical activity, the SenseWear Pro2 armband was applied.
Furthermore, lean body mass, grip strength, mental health
and quality of life were assessed to evaluate their relation-
ship to physical activity.
2. Materials and methods
From October 2008 to April 2009, paediatric IBD patients
were recruited at the Div. of Paediatric Gastroenterology,
Dr. von Hauner Children's Hospital, University of Munich
Medical Centre for the assessment of physical activity and
body composition. Inflammatory bowel disease (IBD) pa-
tients were included in the study if they were between 6
and 20 years of age. The diagnosis of Crohn's disease (CD)
and ulcerative colitis (UC) was established according to ESP-
GHAN criteria.6 At the time of data acquisition, the patients
were in remission or showed only mild disease activity for at
least four weeks. Exclusion criteria were moderate to severe
disease activity, hospitalization, or co-morbidities that
could affect the physical activity. Forty-three eligible patientswere identified. Two patients rejected participation and two
were later excluded from data analysis because of occurrence
of moderate disease activity during the study period, thus
data of 39 patients were evaluated. The patients were pair-
matched for age and sex with 39 healthy controls who were
recruited from friends and schoolmates of the patients. Exclu-
sion criteria for the control group were acute diseases e.g. in-
fections during the last 4 weeks before the evaluation and
chronic disorders or physical disabilities.
The study protocol was approved by the Local Ethical
Committee of the Medical Faculty of the University of
Munich. Informed consent was obtained from the parents,
and from patients and controls as appropriate for their
respective ages.
2.1. Anthropometry and grip force
Height and weight were measured, body mass index (BMI)
was calculated as weight [kg]/(height [m])2. Height, weight
and BMI were compared with longitudinal growth reference
data of German children.7
Bioelectrical impedance analysis was performed with a
multi-channel device at 5, 50 and 100 kHz (Nutriguard M,
Data Input, Darmstadt, Germany). The phase angel α was ap-
plied as a surrogate marker for the quality of lean body mass,
and Z-scores were calculated based on the reference data
from Bosy-Westphal et al and the Data Input compendium.8,9
Maximal isometric grip force of the non-dominant hand
was assessed by an adjustable-handle Jamar Dynamometer
(Preston, Jackson, MI). Reference data for grip force were
taken from Rauch et al.10
2.2. Energy intake
The patients and controls completed a prospective dietary
protocol on three consecutive days (two weekdays and one
weekend day). Energy intake was calculated using the
Prodi 5.2 expert software package (Nutri-Science GmbH,
Freiburg, Germany) using food composition data of Bundes-
lebensmittelschlüssel II. The results were expressed as
percentage of the daily recommended caloric energy intake
for healthy children of the respective age and gender.11
2.3. Physical activity and energy expenditure
The SenseWear Pro2 armband (Bodymedia Inc., Pittsburgh,
Pennsylvania, USA) is a combination of a two-axial acceler-
ometer (longitudinal and transversal) and a multisensor
device, which provides additional information on skin
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base of these measures, the analysis of the armband data
is carried out by the manufacturer's software package Sense-
Wear Professional 6.1 (Bodymedia Inc., Pittsburgh, Pennsyl-
vania, USA). It provides several parameters: the total
metabolic equivalent of task (METs) [kcal per kg body weight
per hour] is an important raw value. The total energy expen-
diture in kcal per day can be calculated by the multiplication
of the average daily METs*kg body weight*24 h. However,
since the total energy expenditure in kcal depends on body
weight, we exclusively used the average METs as a surrogate
marker for the total energy expenditure. Furthermore, the
daily number of steps, the duration of total physical activity
(defined as activities with an energy expenditure of ≥3
METs), the lying down duration and the sleep duration
were recorded. Activity levels ranging from 3 to 6 METs
were arbitrarily considered as moderate and those N6 as
high physical activity, based on Ainsworth et al.12
The armband was worn consecutively for 72 h (2 week-
days, 1 day at the weekend, and parallel to the dietary pro-
tocol) on the right upper arm (regardless of the patient's
handedness) over the triceps brachii muscle mid way be-
tween the acromion and the olecranon. Patients were
instructed to wear the armband continuously and only to re-
move it during the time period when they were having a
shower or a bath. Only armband records with a recording
time of ≥95% were considered. Due to technical problems,
recordings were repeated in one patient and two controls.
2.4. Quality of life
The quality of life (QoL) was assessed by the German KINDL
questionnaire, which is subdivided in three different age
groups: the Kiddy-KINDL for children between 4 and 7 years
of age, the Kid-KINDL for the age group 8 to 11 years and
the Kiddo-KINDL for children and adolescents aged 12 years
and older.13
Each version consists of 24 Likert-scaled items, which are
subdivided in six dimensions (subscales) of quality of life:
physical well-being, emotional well-being, self-worth,
well-being in the family, well-being regarding friendships
and well-being at school. The score of each item ranges
from 1 (never) to 5 (always), while the total of the subscales
and the overall score are calculated from the items' means.
The raw scores are transformed into a 0–100 scale. Higher
scores indicate a better QoL.
Only the patients were asked to complete the IMPACT III,
which is a specific health related quality of life question-
naire for children and adolescents with IBD.14 It consists of
35 questions, subdivided in six different subscales: bowel
symptoms, systemic symptoms, emotional functioning, so-
cial functioning, body image, and treatment. The Likert-
scaled questionnaire offers 5 response options for each
item. Higher scores indicate a better disease-related QoL.
Results for the total score and each subscale are expressed
as percentage of the maximal possible points.
2.5. Patient related parameters
The following IBD-related parameters were assessed in pa-
tients only. The Montreal classification was applied forlocalisation, behaviour and severity of the disease.15 To as-
sess the disease activity, we calculated the Paediatric
Crohn's Disease Activity Index (PCDAI) in CD patients and
the Paediatric Ulcerative Colitis Activity Index (PUCAI) in
UC patients.16,17 Remission was considered if the scores
were lower than 10, mild disease activity was defined as a
PCDAI Score from 10 and 27.5 and a PUCAI Score from 10 to
34. Drug therapy included mesalazine, sulfasalazine, azathi-
oprine, systemic glucocorticoids and anti-TNF-α-antibodies
(Infliximab). The current dose of corticosteroids was
recorded at the time of measurement and the cumulative
lifetime dose (in mg prednisone equivalent) was calculated.
Enteral nutrition therapy was defined as exclusive enteral
feeding with a balanced formula for at least 4 weeks.
Biochemical parameters involve haemoglobin (Hb) [g/dl],
albumin [g/dl], C-reactive protein [CRP] and erythrocyte
sedimentation rate [ESR].2.6. Statistics
Sex-, age- and height-specific Z-scores were calculated using
the formula:
Z-score=[(test result for a patient)− (age and sex-specific
mean in reference population)]/(age and sex-specific stan-
dard deviation in reference population).
Normal distribution was visually checked by histograms
and tested by Kolmogorov–Smirnov. The paired samples
t-test was applied to analyse differences between patients
and controls. Mean and 95% CI were indicated. Since the
results for neither the quality of life scores nor their dif-
ferences were normally distributed, the Wilcoxon rank-
sum test was calculated and median and lower and upper
quartiles were indicated. Tests for differences between
patients and controls were also stratified by gender, by
type of diagnosis and by disease activity (remission and
mild disease). 2-factorial ANOVA was applied to test for
effect-modification between subgroups. All tests were
two tailed, p-values≤0.05 were considered significant.
Statistical analyses were performed by using the software
package PASW Statistics, release 18.0 (SPSS Inc., Chicago,
Illinois, USA).3. Results
All 78 participants completed the protocol. The mean age of
the 39 patients (27 CD, 24 males) was 15.1±2.9 years (mean±
SD, range 7.8–19.3 years) and of the 39 controls 15.2±
3.1 years (range 8.3–20.0). Ileocolonic localisation was ob-
served in 22 of 27 CD patients, ileal localisation only in 2
and colonic only in 3 patients. Ten of the 12 UC patients
had pancolitis, one patient had proctitis and the remaining
child left sided colitis. The patients' data on disease activity
indices, medical and nutritional therapy, and biochemical
markers are summarized in Table 1, separated by type of dis-
ease (CD or UC). At time of data recording, only one patient
with UC was on glucocorticosteroid therapy (8 mg predniso-
lon per day). According to the PCDAI and the PUCAI, two
thirds of each disease group were in remission and one third
had mild disease activity.
Table 1 Age, disease duration and activity, medication, nutritional therapy and biochemical parameters of all patients,
subdivided according to subtype of IBD; median (range) respectively frequency were indicated.
Crohn's disease (n=27) Ulcerative colitis (n=12) All patients (n=39)
Age at diagnosis [y], median (range) 10.9 (4.7–16.8) 11.7 (7.4–17.3) 11.5 (4.7–17.3)
Disease duration [y], median (range) 3.2 (0.2–12.6) 3.1 (0.6–8.1) 3.5 (0.2–12.6)
PCDAI (only CD) a
– Remission [n] (range) 18 (0–7.5)
– Mild activity [n] (range) 9 (10–15)
PUCAI (only UC) a
– Remission [n] (range) 8 (0–7.5)
– Mild activity [n] (range) 4 (10–30)
Medication
5-ASA [n] 21 8 29
Sulfasalazine [n] 5 3 8
Azathioprine [n] 19 9 28
Infliximab [n] 8 1 9
Glucocorticoids ever [n] 12 12 24
Glucocorticoids lifetime dose min–max [mg] 530–15673 1157–10567 530–15673
Nutritional therapy (≥4 weeks, only CD, n=27)
Patients with present nutritional therapy [n] 5 – 5
Patients with nutritional therapy ever [n] 20 – 20
Biochemical parameters, median (range)
Haemoglobin [g/dl] 12.8 (11.4–17.0) 14.0 (11.6–15.8) 13.0 (11.4–17.0)
Albumin [g/dl] 4.6 (3.6–5.3) 4.7 (4.1–5.2) 4.6 (3.6–5.3)
CRP [mg/dl] 0.24 (0.1–2.9) 0.10 (0.1–1.1) 0.17 (0.1–2.9)
ESR [mm/h] 13 (3–62) 16 (1–49) 14 (1–62)
a Normative data for disease activity indices: PCDAI b10=remission, 10–27.5=moderate, 30–37.5=mild, ≥40=severe disease activity;
PUCAI b10=remission, 10–34=mild, 35–64=moderate, and ≥ 65=severe.
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The Z-scores for height, weight, BMI, phase angle α and grip
strength, separated for patients and controls, and the mean
differences of the Z-scores between the matched pairs are
shown in Table 2. Patients showed significantly lower Z-
scores than controls for all parameters (all p≤0.015, pair-
matched t-test). The results were comparable when crude
data were used instead of Z-scores (data not shown).Table 2 Data on anthropometrics, physical activity and energy i
age- and sex-matched pairs; means and 95% CI are indicated.
Patients (n=39)
(Mean, 95% CI)
Height Z-score −0.54 [−0.84; −0.2
Weight Z-score −0.75 [−1.04; −0.4
BMI Z-score −0.56 [−0.83; −0.2
Grip force Z-score (n=32) −0.34 [−0.72; 0.42
Phase angle α Z-score (n=38) −0.64 [−0.95; −0.3
Number of steps 9828 [8937; 10,718
Duration of physical activity [h] (N3 METs) 2.29 [1.96; 2.63]
– Moderate (3–6 METs) 2.01 [1.71; 2.31]
– High (N 6 METs) 0.28 [0.20; 0.36]
Lying down duration 9.10 [8.75; 9.46]
Sleeping duration 7.14 [6.80; 7.48]
Mean METs [kcal/h/kg body weight] 1.66 [1.60; 1.72]
Energy intake [in % of daily recommendation] 80.0 [73.1; 86.8]While separate analysis for Z-score differences between
CD patients and controls showed significant negative results
(all p≤0.021), CU patients did not differ from their healthy
matches in height, weight, BMI and grip strength, but phase
angleαwas also reduced (p=0.002) (Table 3). Similarly, female
patients only differed significantly from their healthy control in
phase angle α Z-scores (p=0.018), but males in all parameters
(all p≤0.013). A possible effect-modification between sex





4] 0.18 [−0.12; 0.47] −0.72 [−1.14; −0.30]
6] −0.35 [−0.31; 0.23] −0.71 [−1.08; −0.34]
8] −0.15 [−0.39; 0.10] −0.41 [−0.74; −0.08]
] 0.83 [0.41; 1.24] −1.02 [−1.58; −0.47]
4] 0.09 [−0.16; 0.35] −0.72 [−1.10; −0.34]
] 11,166 [10,060; 12,272] −1339 [−2760; 83]
2.74 [2.33; 3.14] −0.44 [−0.94; 0.057]
2.36 [1.97; 2.76] −0.35 [−0.79; 0.09]
0.42 [0.29; 0.54] −0.14 [−0.28; 0.00]
8.70 [8.30; 9.09] 0.41 [−0.04; 0.85]
6.73 [6.40; 7.06] 0.41 [−0.02; 0.85]
1.73 [1.65; 1.80] 0.06 [0.03; 0.81]
85.9 [80.4; 91.4] −5.9 [−16.0; 4.2]
Table 3 Differences between the age-and sex-matched pairs for anthropometrics, physical activity and energy intake, stratified by sex, type of diagnosis and disease status
(remission or mild disease); means and 95% CI are indicated.
Differences between patients and pair-matched controls




Height Z-score −0.77 [−1.35; −0.19] −0.64 [−1.31; 0.03] −0.96 [−1.47; −0.45] −0.18 [−0.94; 0.59] −0.51 [−0.98; −0.04] −1.15 [−2.05; −0.25]
Weight Z-score −0.92 [−1.45; −0.39] −0.37 [−0.86; 0.12] −0.81 [−1.20; −0.43] −0.48 [−1.43; 0.47] −0.50; [−0.93; −0.08] −1.13 [−1.87; −0.38]
BMI Z-score −0.63 [−1.09; −0.16] −0.06 [−0.49; 0.36] −0.37 [−0.60; −0.06] −0.51 [−1.42; 0.41] −0.33 [−0.69; 0.19] −0.57 [−1.34; 0.20]
Grip force Z-score −1.40 [−2.14; −0.67] −0.54 [−1.43; 0.35] −1.27 [−1.96; −0.57] −0.49 [−1.53; 0.54] −0.94 [−1.65; −0.23] −1.19 [−2.25; −0.13]
Phase angle α Z-score −0.54 [−0.94; −0.13] −1.04 [−1.86; −0.21] −0.57 [−1.08; −0.06] −1.05 [−1.61; −0.49] −0.40 [−0.84; 0.04] −1.34 [−2.01; −0.66]
Number of steps −1208 [−3089; 672] −1547 [−3994; 900] −1515 [−3133; 104] −943 [−4220; 2334] −1041 [−2862; 780] −1934 [−4495; 628]
Duration of physical activity
[h] (N3 METs)
−0.19 [−0.87; 0.49] −0.84 [−1.59; −0.09] −0.14 [−0.65; 0.38] −1.12 [−2.29; 0.046] 0.23 [−0.83; 0.38] −0.86 [−1.82; 0.09]
– Moderate (3–6 METs) −0.15 [−0.76; 0.46] −0.68 [−1.34; −0.03] −0.07 [−0.51; 0.36] −0.98 [−2.05; 0.09] −0.22 [−0.81; 0.37] −0.62 [−1.32; 0.07]
– High (N6 METs) −0.12 [−0.31; 0.07] −0.16 [−0.39; 0.06] −0.07 [−0.22; 0.08] −0.29 [−0.62; 0.03] −0.09 [−0.22; 0.05] −0.24 [−0.59; 0.11]
Lying down duration [h] 0.42 [−0.08; 0.91] 0.39 [−0.55; 1.33 ] 0.29 [−0.28; 0.86] 0.67 [−0.12; 1.45] 0.14 [−0.36; 0.64] 0.94 [0.09; 1.87]
Sleeping duration [h] 0.42 [−0.06; 0.89] 0.39 [−0.52; 1.29] 0.44 [−0.10; 0.99] 0.33 [−0.47; 1.12] 0.12 [−0.40; 0.63] 0.99 [0.24; 1.74]
Mean METs
[kcal/h/kg body weight]
−0.04 [−0.16; 0.09] −0.11 [−0.24; 0.18] −0.03 [−0.11; 0.06] −0.16 [−0.39; 0.07] −0.02 [−0.12; 0.08] −0.17 [−0.35; 0.02]
Energy intake [in % of daily
recommendation]







Figure 1 Duration of physical activity in female patients com-
pared to their age- and sex-matched controls.
Figure 2 Duration of physical activity in patients with mild
disease activity compared to their age- and sex-matched
controls.
670 K.J. Werkstetter et al.Stratified for disease activity, there was a trend towards
lower phase angle α Z-scores for patients in remission com-
pared to controls (p=0.075), while a significant difference
was detected for patients with mild disease activity
(p=0.001). The phase angel alpha as indicator for lean
body mass correlated with the grip strength (r=0.60,
pb0.001 overall and r=0.57, pb0.001 for patients).
3.2. Energy intake
Overall, patients and controls did not differ in energy intake
expressed as % of the daily reference intakes for age and
gender. However, patients with mild disease activity tended
towards a lower energy intake (−19.3 %) than their matched
controls (p=0.059).
3.3. Physical activity and energy expenditure
The differences in duration of physical activity and number
of steps between patients and controls did not reach signifi-
cance. However, a strong trend was noticed especially for a
reduced duration of high-level physical activity (p=0.051) in
patients and also for the number of steps (p=0.064); in con-
trast, sleep duration seemed to be prolonged (p=0.061)
(Table 3).
Stratified for the type of disease, the differences be-
tween healthy controls and both CD or UC patients were
not significant. However, UC patients tended towards a
shorter duration of physical activity (p=0.058) and CD pa-
tients towards less number of steps (p=0.065). Female pa-
tients had a significantly shorter duration of physical
activity (in total and on a moderate level) than their
matched controls (p=0.03 and p=0.042) (Fig. 1); male pa-
tients showed a trend towards a longer sleep duration
(p=0.081). In patients with mild disease activity, a trend to-
wards lower duration of physical activity (p=0.075) (Fig. 2)
and significantly prolonged sleep duration (p=0.014) were
detected, while there were no significant differences be-
tween the patients in the remission group and their respec-
tive controls. There was no effect-modification between
sex and disease activity status.
3.4. Quality of life
Overall and in the stratified analyses, patients and controls
did not differ in the scores of the KINDL questionnaire
(data not shown). The scores of the IBD-specific IMPACT III
were as follows (median and lower and upper quartiles):
total score 83 (range 79–87), bowel symptoms 86 (80–91),
systemic symptoms 80 (80–93), emotional functioning 80
(69–89), social functioning 87 (83–92), body image 80
(67–87), and treatment 80 (67–87). No significant correla-
tion was found between physical activity and the KINDL
score or the health related quality of life score of the IM-
PACT III (patients only).
4. Discussion
Our study reveals that children and adolescents with well-
controlled IBD show lower physical activity, particularly ingirls and in patients with mild disease activity. Although
the difference just missed statistical significance in the
moderate number of patients studied, the effect size of
the observed trend seems clinically relevant with much less
steps taken per day (~1000 in patients in remission and
~2000 in mild disease) and almost half an hour less physical
activity per day, and ~30 min more sleeping time. Even a
mild disease activity appeared to have a marked effect on
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knowledge, our data present the first evaluation on physical
activity and sleeping duration in paediatric IBD applying a
multisensory accelerometer during normal daily life
conditions.
In accordance with publications on other paediatric IBD
cohorts,18–21 our patients had reduced Z-scores for height,
weight and BMI; this was particularly marked in males and
in CD patients. Body composition, especially lean body
mass (LBM), may reflect the nutritional situation more accu-
rately than BMI. Reduced LBM and reduced muscle mass have
already been described in paediatric IBD patients22–25 and
may have negative long-term effects on the physical fitness
and the bone health.26,27 We assessed LBM by bioelectrical
impedance phase angle α. This parameter is a raw value,
therefore independent of weight and less prone to assump-
tions used for calculation of LBM and other parameters.28
In all subgroups, the phase angle α Z-scores were lower in
the patients than in the controls indicating a reduced LBM
even in patients in remission. The reduced dynamometric
grip force over all patients and in particular for males and
CD patients reflects the functional deficits of the muscle
mass. This finding supports the assumption that a low
phase angel α indicates decreased LBM. In a longitudinal co-
hort study with CD children, BMI and clinical symptoms im-
proved two years after initial diagnosis, but initially low
LBM did not.26 It was reported that inflammation, glucocor-
ticosteroid therapy, anorexia and malnutrition contribute to
the loss of LBM respectively muscle mass in patients with CD
and UC.24 Besides treatment and nutritional effects, physi-
cal activity may play a key role to regain and maintain the
musculature in children and adolescents with IBD. Our re-
sults indicate that IBD patients seem to change their lifestyle
resulting in less steps and sportive activities even during
phases of remission.
In our cohort, the SenseWear Pro2 armband was applied
to assess physical activity and energy expenditure. The arm-
band was validated in children and adolescents against indi-
rect calorimetry; however, it tends to overestimate low
levels and underestimate high levels of physical activity.29,30
For our data, these limitations have only a minor impact,
since we compared patients with healthy age- and sex-
matched controls using the same method. The advantage
of the armband over indirect calorimetry is its applicability
under daily life condition. Our data failed to reach an overall
statistical significance, presumably due to an underpowered
sample size even though we recruited a sizeable number of
children with quiescent disease into this study. However,
we found a strong trend towards reduced general physical
activity in patients compared to healthy controls, as indicat-
ed by a lesser number of steps and a shorter duration of
physical activity. This is most pronounced in girls with signif-
icant shorter physical activity duration in total and on a
moderate level compared to their controls. Reduced physi-
cal activity may negatively affect the health status of the
IBD patients in several ways. The general fitness is likely to
be impaired, which may not only result in reduced physical
condition, functional ability and motor skills; the risk for
several health problems associated with hypoactivity, e.g.
cardiovascular conditions, or type 2 diabetes, may also in-
crease.4 Impaired bone density in paediatric patients and
increased risk for osteoporosis in adults are already a well-known problem in IBD.22,25,31 Several reviews emphasize
the major role of muscle and physical activity on bone
growth and strength in healthy children and adolescents,
particularly during puberty.2,32–35 The bone remodelling
mechanism hypothesis suggests that physical activity influ-
ences bone metabolism both directly and indirectly by mus-
cle innervations via mechanical loads. If these dynamic
strains exceed an upper threshold, an interstitial fluid flow
mediates the mechanical signals to osteoblasts, which in-
duce bone formation.32,36 Weight-bearing activities like
gymnastics, running or jumping activities induce high dy-
namic loads and therefore enhance bone formation.37 The
impact of an increase in physical activity on the bone
strength of paediatric IBD patients had not been examined
yet. One prospective randomized controlled intervention
study investigated the effects of a home-based low-impact
exercise program in 107 adult CD patients and reported pos-
itive effects on the bone density in the exercise group.38
Since the highest capacity to maximize bone strength ap-
pears to exist in the pre- and peripubertal phase, this win-
dow of opportunity should be exploited in paediatric IBD,
in addition to an adequate pharmacological and nutritional
therapy.
In addition to positive effects on physical condition, exer-
cise may also benefit mental health. Improved cognitive de-
velopment and psycho-social factors like self-esteem and
quality of life are described.39,40 The latter is frequently im-
paired in children and adolescents with IBD.41 We found no
difference between patients and controls in QoL as assessed
by the KINDL questionnaire. The results of the paediatric
IBD-specific Impact III questionnaire support a good QoL in
the majority of our patients and reflect the well-controlled
disease activity.14 Since we included only patients with qui-
escent disease, no significant relation was found between in-
flammatory markers such as CRP and QoL or physical
activity. This is in contrast to studies in adult IBD patients
with a larger range of disease severity which reported an as-
sociation between physical activity and inflammatory
markers or disease activity, respectively,42.40 However, ev-
idence is lacking that physical activity itself has an impact
on the inflammatory process, and reverse causality appears
to be the most likely explanation for their finding. In our pa-
tient group we did not find any significant relation between
physical activity and QoL score. However, our study design
does not allow final conclusion regarding the relation of
physical activity and mental health and QoL in paediatric
IBD patients. IBD patients tend to dissimulate and underre-
port symptoms. Therefore, a prospective randomized con-
trolled intervention trial with an intra-individual
comparison before and after an intervention program and
no intervention may be more appropriate to investigate the
impact of increased physical activity on the different out-
come parameters.
In conclusion, we found significantly reduced lean body
mass, a trend towards low physical activity and normal qual-
ity of life in paediatric IBD patients with well-controlled dis-
ease activity, compared to age- and sex-matched controls.
Since physical exercise and muscle mass play a major role
in the physical and mental development of growing children
and adolescents and may have long-term effects on health
and well-being, an enhanced physical activity in addition
to the inflammatory and nutritional management might
672 K.J. Werkstetter et al.improve the situation of these patients. To test this hypoth-
esis, a prospective randomized controlled intervention study
with long-term follow up should examine the effects of phys-
ical activity on muscle mass and general physical health, es-
pecially on bones, and on mental conditions.
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